TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06205121: Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

Sponsor: Molecure S.A. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 96 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$2,556,400

Rescue Site Savings

+$1,693,200

Unlock Full NCT06205121 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06205121 Rescue Dossier →